Daily non-political popular news in brief.

Cancer drug can extend survival in patients with deadly brain tumors

02-20-2007 · EurekAlert!

Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.

Keywords: cancer, drug, extend, survival, patients, deadly, brain, tumors, patient, tumor

« Previous | Next »

Similar news on "Cancer drug can extend survival in patients with deadly brain tumors":

Drug combination might offer hope for patients deadly brain tumors
10-18-2007 · EurekAlert!
Brain cancer patients with the poorest prognosis -- those with a type of deadly tumor known as glioblastoma multiforme -- may survive longer with a drug that chokes off a tumor's blood supply.
Similar news · Read more »
New angiogenesis inhibitor has promise for treating deadly brain tumor
01-16-2007 · EurekAlert!
Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
Similar news · Read more »
Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
01-30-2008 · EurekAlert!
In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
Similar news · Read more »
Drug study for brain cancer shows promising results
12-13-2007 · EurekAlert!
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Similar news · Read more »
Pancreatic cancer: The smaller the tumor, the better your chances, study shows
01-28-2008 · EurekAlert!
The odds of surviving cancer of the pancreas increase dramatically for patients whose tumors are smallest, according to a new study by researchers at Saint Louis University and the M.D. Anderson Cancer Center in Houston -- the first study to specifically evaluate the link between tumor size and survival rates for one of the most common and deadly cancers.
Similar news · Read more »
Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
12-13-2006 · EurekAlert!
Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found.
Similar news · Read more »
Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
12-14-2006 · UT Southwestern Medical Center
Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found.
Similar news · Read more »
New biomarker predicts effectiveness of breast cancer drugs
12-07-2006 · EurekAlert!
University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
Similar news · Read more »
Experimental drug shows promise in advanced kidney cancer
09-26-2007 · EurekAlert!
A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
Similar news · Read more »
Blood-vessel blocker aids cancer-killing virus
11-27-2007 · EurekAlert!
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
Similar news · Read more »